A study on the encapsulation of an occludin lipophilic derivative in liposomal carriers

Sarha Cupri,Adriana C. E. Graziano,Venera Cardile,Mariusz Skwarczynski,Istvan Toth,Rosario Pignatello
DOI: https://doi.org/10.3109/08982104.2014.992025
2015-01-14
Journal of Liposome Research
Abstract:Many peptides and proteins, although potentially useful for the treatment of various diseases, are hindered in their clinical use by poor oral absorption and rapid enzymatic degradation. One of the available solutions to these problems is to increase the lipophilicity by conjugating the peptides to lipophilic moieties, making them more able to cross the biomembranes by passive transport. Occludin is a 65-kDa integral plasma-membrane protein located at the tight junctions. This protein and the peptide derived from it have potential clinical application for drug delivery. Peptide OP90-103 (1) is a fragment of occludin that shows a very poor oral bioavailability and is highly susceptible to enzymatic degradation. The conjugation of 1 with two lipoamino acid (LAA) moieties has been shown to enhance its lipophilicity and bioavailability, as well as its enzymatic stability. The purpose of this study was to evaluate the possibility of encapsulating fluorescein modified lipidated OP90-103 (2), in unilamellar- (LUV) and multilamellar liposomes (MLV), which have a different composition and surface charge and are produced by different methods. The cell internalization of the carrier systems was evaluated in vitro.
pharmacology & pharmacy,biochemistry & molecular biology
What problem does this paper attempt to address?